In this interview, Dr. Makoto Arita sheds light on his recent research exploring the metabolites and metabolic pathways that contribute to the anti-inflammatory and inflammation-resolving properties of omega-3. He delves deeper into the nature of specialized pro-resolving mediators (SPMs) and how they are a cascade of metabolites. Dr. Arita also talks about various conditions, including cardiovascular diseases, where SPMs have proven advantageous. He concludes by addressing how individual health status and enzyme functionality might dictate the required amount of SPM for each person.
Makoto Arita, PhD, is a Professor of Physiological Chemistry and Metabolism at the Graduate School of Pharmaceutical Sciences, Keio University.
From the 17th International Conference on Bioactive Lipids in Cancer, Inflammation and Related Diseases, October 2022 in New Orleans, Louisiana
